Current HIV/AIDS Reports

, Volume 10, Issue 2, pp 152–158

Antiretroviral Therapy for Prevention Is a Combination Strategy

  • Margaret L. McNairy
  • Myron Cohen
  • Wafaa M. El-Sadr
The Global Epidemic (Q Abdool Karim, Section Editor)

DOI: 10.1007/s11904-013-0152-1

Cite this article as:
McNairy, M.L., Cohen, M. & El-Sadr, W.M. Curr HIV/AIDS Rep (2013) 10: 152. doi:10.1007/s11904-013-0152-1


In the past several years, the debate of “treatment vs prevention” has shifted with the introduction of the concept of “treatment as prevention,” (TasP), stemming from a series of compelling observational, ecological, and modeling studies as well as HPTN 052, a randomized clinical trial, demonstrating that use of ART is associated with a decrease in HIV transmission. In addition to TasP being viewed as 1 intervention in a combination strategy for HIV Prevention, TasP is, in and of itself, a combination of multiple interventions that need to be implemented with high coverage in order to achieve its potential impact.


HIVAntiretroviral therapyHIV preventionTreatment as prevention (TasP)Global epidemicCombination intervention

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Margaret L. McNairy
    • 1
    • 2
  • Myron Cohen
    • 3
  • Wafaa M. El-Sadr
    • 1
  1. 1.ICAP-Columbia UniversityMailman School of Public HealthNew YorkUSA
  2. 2.Weill-Cornell Medical CollegeNew YorkUSA
  3. 3.University of North CarolinaChapel HillUSA